Literature DB >> 31702900

Deletion of the Mitochondrial Protein VWA8 Induces Oxidative Stress and an HNF4α Compensatory Response in Hepatocytes.

Moulun Luo1, Wayne T Willis1, Dawn K Coletta1, Paul R Langlais1, April Mengos2, Wuqiong Ma1, Jean Finlayson1, Gregory R Wagner3, Chang-Xin Shi2, Lawrence J Mandarino1.   

Abstract

von Willebrand A domain-containing protein 8 (VWA8) is a poorly characterized, mitochondrial matrix-targeted protein with an AAA ATPase domain and ATPase activity that increases in livers of mice fed a high-fat diet. This study was undertaken to use CRISPR/Cas9 to delete VWA8 in cultured mouse hepatocytes and gain insight into its function. Unbiased omics techniques and bioinformatics were used to guide subsequent assays, including the assessment of oxidative stress and the determination of bioenergetic capacity. Metabolomics analysis showed VWA8 null cells had higher levels of oxidative stress and protein degradation; assays of hydrogen peroxide production revealed higher levels of production of reactive oxygen species (ROS). Proteomics and transcriptomics analyses showed VWA8 null cells had higher levels of expression of mitochondrial proteins (electron transport-chain Complex I, ATP synthase), peroxisomal proteins, and lipid transport proteins. The pattern of higher protein abundance in the VWA8 null cells could be explained by a higher level of hepatocyte nuclear factor 4 α (HNF4α) expression. Bioenergetic assays showed higher rates of carbohydrate oxidation and mitochondrial and nonmitochondrial lipid oxidation in intact and permeabilized cells. Inhibitor assays localized sites of ROS production to peroxisomes and NOX1/4. The rescue of VWA8 protein restored the wild-type phenotype, and treatment with antioxidants decreased the level of HNF4α expression. Thus, loss of VWA8 produces a mitochondrial defect that may be sensed by NOX4, leading to an increase in the level of ROS that results in a higher level of HNF4α. The compensatory HNF4α response results in a higher oxidative capacity and an even higher level of ROS production. We hypothesize that VWA8 is an AAA ATPase protein that plays a role in mitochondrial protein quality.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31702900      PMCID: PMC8925280          DOI: 10.1021/acs.biochem.9b00863

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

Review 1.  ClpXP, an ATP-powered unfolding and protein-degradation machine.

Authors:  Tania A Baker; Robert T Sauer
Journal:  Biochim Biophys Acta       Date:  2011-06-27

2.  Glutathione and γ-glutamylcysteine in hydrogen peroxide detoxification.

Authors:  Ruben Quintana-Cabrera; Juan P Bolaños
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

3.  Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays.

Authors:  Eugene Bolotin; Hailing Liao; Tuong Chi Ta; Chuhu Yang; Wendy Hwang-Verslues; Jane R Evans; Tao Jiang; Frances M Sladek
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

4.  Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.

Authors:  Jia-Lin Xu; Li-Ya Li; Yan-Qing Wang; Ya-Qi Li; Mu Shan; Shi-Zhuo Sun; Yang Yu; Bing Wang
Journal:  J Lipid Res       Date:  2017-11-07       Impact factor: 5.922

5.  RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network.

Authors:  Kyeongkyu Kim; Kyungjin Boo; Young Suk Yu; Se Kyu Oh; Hyunkyung Kim; Yoon Jeon; Jinhyuk Bhin; Daehee Hwang; Keun Il Kim; Jun-Su Lee; Seung-Soon Im; Seul Gi Yoon; Il Yong Kim; Je Kyung Seong; Ho Lee; Sungsoon Fang; Sung Hee Baek
Journal:  Nat Commun       Date:  2017-07-31       Impact factor: 14.919

6.  NHR-49/HNF4 integrates regulation of fatty acid metabolism with a protective transcriptional response to oxidative stress and fasting.

Authors:  Grace Y S Goh; Johnathan J Winter; Forum Bhanshali; Kelsie R S Doering; Regina Lai; Kayoung Lee; Elizabeth A Veal; Stefan Taubert
Journal:  Aging Cell       Date:  2018-03-05       Impact factor: 9.304

7.  High Fat Diet-Induced Changes in Hepatic Protein Abundance in Mice.

Authors:  Moulun Luo; April E Mengos; Tianna M Stubblefield; Lawrence J Mandarino
Journal:  J Proteomics Bioinform       Date:  2012-02-29

8.  Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes.

Authors:  Hyonson Hwang; Benjamin P Bowen; Natalie Lefort; Charles R Flynn; Elena A De Filippis; Christine Roberts; Christopher C Smoke; Christian Meyer; Kurt Højlund; Zhengping Yi; Lawrence J Mandarino
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

9.  Quantitative microplate-based respirometry with correction for oxygen diffusion.

Authors:  Akos A Gerencser; Andy Neilson; Sung W Choi; Ursula Edman; Nagendra Yadava; Richard J Oh; David A Ferrick; David G Nicholls; Martin D Brand
Journal:  Anal Chem       Date:  2009-08-15       Impact factor: 6.986

10.  NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance.

Authors:  Karthigayan Shanmugasundaram; Bijaya K Nayak; William E Friedrichs; Dharam Kaushik; Ronald Rodriguez; Karen Block
Journal:  Nat Commun       Date:  2017-10-19       Impact factor: 14.919

View more
  2 in total

1.  Metabolomic and transcriptomic profiling reveals the alteration of energy metabolism in oyster larvae during initial shell formation and under experimental ocean acidification.

Authors:  Zhaoqun Liu; Yukun Zhang; Zhi Zhou; Yanan Zong; Yan Zheng; Chang Liu; Ning Kong; Qiang Gao; Lingling Wang; Linsheng Song
Journal:  Sci Rep       Date:  2020-04-09       Impact factor: 4.379

2.  Deletion of Von Willebrand A Domain Containing Protein (VWA8) raises activity of mitochondrial electron transport chain complexes in hepatocytes.

Authors:  Moulun Luo; Wuqiong Ma; Rocio Zapata-Bustos; Wayne T Willis; Lawrence J Mandarino
Journal:  Biochem Biophys Rep       Date:  2021-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.